News

PPD PatientView is a part of PPD Adaptive Solutions, the suite of customizable, flexible and integrated technology solutions that PPD deploys to meet each client’s needs in advancing

BASF is conducting feasibility study to assess the technical, commercial and economic viability of operating a world-scale complex in Brazil. Following the completion of feasibility study, which is

The new production facility will have an initial capacity of 20,000 metric tonnes per year, and will produce high-tech plastics – Durethan and Pocan. To produce Durethan and

This follows the positive opinion on the designation that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency adopted previously in the November 2010 COMP

The company’s lead drug candidate, GO-203-2c is currently being studied in a Phase I trial which aims to determine the safety and tolerability, and potential anti-tumor activity of

The trial aimed to determine the safety, efficacy, tolerability and pharmacokinetics of X-Excite in men on side by side study with Pfizer’s Viagra. Reportedly, the study evaluated total

RECALL-VAXTM is a method to immunize people to produce specific natural antibodies against the beta amyloid (Aß) protein before it causes irreversible damage by accumulating in the brains

Qualitix is a full service CRO based in Taipei, Taiwan and Shanghai, China, and engaged in clinical monitoring and site management services for multinational clinical trials. With this

The extended dose interval of Somatuline Depot 120mg of 6 to 8 weeks is expected to offer patients with acromegaly who are currently controlled on Somatuline Depot 60mg